Stelara to be Replaced on Navitus Formulary With Money-Saving Biosimilars 

Stelara biosimilars Yesintek and Steqeyma have been added to the Navitus formulary effective April 1, 2025. Stelara will be removed from the Navitus formulary effective July 1, 2025. This transition will affect employees of Vanderbilt University Medical Center and Cookeville Regional Medical Center who are insured through their employer-sponsored health plans. The anticipated savings from this update are significant, with potential reductions of approximately $10,000 per prescription fill.